Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Janssen Research & Development, LLC
Inmune Bio, Inc.
AbbVie
Center for International Blood and Marrow Transplant Research
Takeda
Emory University
Cancer Research UK
Center for International Blood and Marrow Transplant Research
AbbVie
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
Cancer Research UK
M.D. Anderson Cancer Center
Constellation Pharmaceuticals
PharmaEssentia
AbbVie
Florida International University
M.D. Anderson Cancer Center
Cogent Biosciences, Inc.
Thomas Jefferson University
Stanford University
AbbVie
Ann & Robert H Lurie Children's Hospital of Chicago
GlaxoSmithKline
Takeda
University Health Network, Toronto
Amgen
GlaxoSmithKline
University of Kansas Medical Center
Northwestern University
AbbVie
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
AbbVie
University of Nebraska
Asana BioSciences
GlaxoSmithKline
Takeda
Takeda
Technische Universität Dresden
Roswell Park Cancer Institute
Novartis
Case Comprehensive Cancer Center
Phoenix Children's Hospital
Radboud University Medical Center
Jonsson Comprehensive Cancer Center
Celgene
National Institutes of Health Clinical Center (CC)
Celgene